APOE and fatty liver disease: Previous reports demonstrated that constitutive transgenic expression of scFv-E06 via the Apoe promoter protected Ldlr−/− mice fed a high-cholesterol diet from hepatic steatosis and ensuing steatohepatitis (35, 38).